October 2025 in “Plastic & Reconstructive Surgery” MNC-QQ cell therapy improved hair growth and quality of life in men with androgenic alopecia without adverse effects.
The combination of minoxidil, microneedling, and PRP is more effective for hair growth than minoxidil alone.
January 2025 in “International Journal of Trichology” Severe hair loss may increase the risk of dying from COVID-19.
January 2024 in “International Ayurvedic medical journal” Certain Prakruti types are more prone to early male pattern baldness.
August 2023 in “Journal of Cosmetic Dermatology” Using a laser with minoxidil was more effective for hair loss than minoxidil alone.
August 2023 in “Clinical, Cosmetic and Investigational Dermatology” Different types of female pattern hair loss have unique characteristics and are associated with various health conditions.
April 2023 in “Pakistan Journal of Medical and Health Sciences” Platelet rich plasma treatment is effective for hair loss in both men and women.
March 2021 in “Indian Journal of Dermatology” A man unhappy with his old hair restoration got a new, natural-looking hairline using a combination of follicular unit extraction and punch graft reduction.
January 2021 in “Skinmed” CEOs aged 50-69 have less significant hair loss than the general white male population.
CEOs aged 50-69 have less significant hair loss than the general white male population.
Platelet-rich plasma injections effectively treat hair loss in both men and women, increasing hair density with high patient satisfaction and no significant side effects.
October 2013 in “Journal of the American College of Cardiology” Men with male pattern baldness have increased arterial stiffness.
January 2010 in “Ciencia UANL” Young men with hair loss may have a higher risk of insulin resistance and related health issues.
December 2022 in “Pakistan Armed Forces Medical Journal” Androgenetic alopecia may increase the severity of COVID-19.
October 2022 in “Hair Transplantation” Male pattern hair loss is mainly caused by genetics and hormones, especially DHT.
PRP with microneedling is more effective than PRP alone for treating hair loss.
April 2022 in “Journal of the Medical Sciences” More severe hair loss worsens quality of life in men.
December 2021 in “Cureus” Minoxidil alone is the most cost-effective treatment for male hair loss at a $50,000 threshold.
December 2021 in “Biomarkers” Men with early baldness have similar heart risk factors as others, but certain proteins are linked to higher heart disease risk.
October 2021 in “DOAJ (DOAJ: Directory of Open Access Journals)” Trichoscopy effectively distinguishes between severe and mild male pattern hair loss.
October 2020 in “Journal of Pakistan Association of Dermatology” Platelet-rich plasma therapy is more effective than minoxidil lotion for increasing hair count in men with hair loss, with mild side effects and high satisfaction.
Androgenetic alopecia may be linked to severe COVID-19.
Most severe COVID-19 patients had hair loss, suggesting a possible link.
Microneedling with PRP is more effective and satisfying for male pattern hair loss than microneedling with minoxidil.
January 2020 in “Skinmed” Microneedling with platelet-rich plasma showed quicker improvements in male pattern hair loss than microneedling with 5% topical minoxidil, with no serious side effects.
August 2019 in “Journal of The American Academy of Dermatology” No link found between hair loss severity and PSA levels in men.
January 2018 in “프로그램북(구 초록집)” No link between hair loss severity and PSA levels in men.
January 2017 in “IP Indian journal of clinical and experimental dermatology” Early-onset male baldness is not linked to insulin resistance, but is significantly associated with metabolic syndrome.
July 2016 in “IP Indian journal of clinical and experimental dermatology” PRP is effective in treating male pattern baldness.
January 2016 in “Springer eBooks” The document explains how hair loss in men and women, known as Androgenetic alopecia, is categorized using the Hamilton-Norwood system for men and the Ludwig grade system for women.